Who owns the SCINTIMUN trademark?

The SCINTIMUN trademark is owned by Telix Pharmaceuticals Limited.

What is the serial number for SCINTIMUN?

The USPTO serial number for SCINTIMUN is 79429309.

What is the registration number for SCINTIMUN?

SCINTIMUN is registered under USPTO registration number 8374643.

SCI

USPTO Trademark Record

REGISTERED

SCINTIMUN

Q: What class is the SCINTIMUN trademark registered in?

The SCINTIMUN trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 010 (Surgical, medical, dental & veterinary apparatus).

SN 79429309·Reg 8374643·Filed Mar 14, 2025

Owner Telix Pharmaceuticals Limited

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Surgical, medical, dental and veterinary apparatus and instruments; artificial limbs, eyes and teeth; spectacles, contact lenses and sunglasses; orthopaedic articles; suture materials; therapeutic and assistive devices adapted for persons with disabilities; massage apparatus; apparatus, devices and articles for nursing infants; sexual activity apparatus, devices and articles.

SCINTIMUN (Serial No. 79429309), Registration No. 8374643, is a registered US trademark filed on Mar 14, 2025 by Telix Pharmaceuticals Limited. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 010 (Surgical, medical, dental & veterinary apparatus).

early section 8: August 04, 2032

Mark Intelligence

SCINTIMUN (Reg. #8374643) is a registered US trademark that has been protecting its owner, Telix Pharmaceuticals Limited, since 2025. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 010 (Surgical, medical, dental & veterinary apparatus) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Mar 14, 2025

SERIAL

79429309

REG#

8374643

REGISTERED

Aug 04, 2026

Owner

Applicant

Telix Pharmaceuticals Limited

Entity

Not Provided

Address

Suite 401,, 55 Flemington Road North Melbourne VIC 3051

Country

Attorney

NameAndrew S. Ehard

Address

P.O. Box 2910, Minneapolis, MN 55402, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateMar 14, 2025

Serial Number79429309

Registration No.8374643

Registration DateAug 04, 2026

Status DateAug 04, 2026

Published for OppositionJun 16, 2026

Mark TypeStandard characters

Status DescriptionLive and registered

Filing Signals

FILED

2025

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

Class 010Surgical, medical, dental & veterinary apparatus

US codes: 026, 039, 044

Surgical, medical, dental and veterinary apparatus and instruments; artificial limbs, eyes and teeth; spectacles, contact lenses and sunglasses; orthopaedic articles; suture materials; therapeutic and assistive devices adapted for persons with disabilities; massage apparatus; apparatus, devices and articles for nursing infants; sexual activity apparatus, devices and articles.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

26 events

REGISTERED-PRINCIPAL REGISTER

Aug 04, 2026

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Aug 04, 2026

NOTICE OF REGISTRATION CONFIRMATION EMAILED

NEW REPRESENTATIVE AT IB RECEIVED

Jul 30, 2026

NEW REPRESENTATIVE AT IB RECEIVED

PUBLISHED FOR OPPOSITION

Jun 16, 2026

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jun 16, 2026

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jun 10, 2026

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

EXAMINERS AMENDMENT -WRITTEN

May 19, 2026

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

May 19, 2026

EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

May 19, 2026

EXAMINER'S AMENDMENT ENTERED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

May 19, 2026

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

May 19, 2026

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Apr 30, 2026

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Apr 30, 2026

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Apr 30, 2026

TEAS/EMAIL CORRESPONDENCE ENTERED

NEW REPRESENTATIVE AT IB RECEIVED

Jan 22, 2026

NEW REPRESENTATIVE AT IB RECEIVED

Jan 01, 2026

NEW REPRESENTATIVE AT IB RECEIVED

REFUSAL PROCESSED BY IB

Nov 30, 2025

REFUSAL PROCESSED BY IB

REFUSAL PROCESSED BY MPU

Nov 09, 2025

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Nov 09, 2025

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Sep 19, 2025

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Sep 18, 2025

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Sep 16, 2025

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 15, 2025

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

APPLICATION FILING RECEIPT MAILED

Sep 15, 2025

APPLICATION FILING RECEIPT MAILED

LIMITATION FROM ORIGINAL APPLICATION ENTERED

Sep 13, 2025

LIMITATION FROM ORIGINAL APPLICATION ENTERED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Aug 07, 2025

SN ASSIGNED FOR SECT 66A APPL FROM IB

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Recently filed and registered marks in the same international class.

SCI

SCINTIMUN

76515906

BAYER SCHERING PHARMA AKTIENGESELLSCHAFT

ABANDONED

SCINTIMUN

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Telix Pharmaceuticals Limited

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Andrew S. Ehard

Resources

Company